Syneos Health Schedules Fourth Quarter and Full Year 2020 Earnings Call for Thursday, February 18, 2021
Syneos Health (Nasdaq:SYNH) will release its fourth quarter and full year 2020 financial results on February 18, 2021, before an earnings call at 8:00 a.m. ET. The call can be accessed via webcast on the company's Investor Relations page. A replay will be available after 1:00 p.m. on the same day. Syneos Health is a fully integrated biopharmaceutical solutions organization, employing approximately 25,000 professionals across over 110 countries, dedicated to accelerating the delivery of therapies.
- Upcoming earnings call scheduled for February 18, 2021, indicating regular financial updates.
- Syneos Health's extensive operational scale with approximately 25,000 employees.
- None.
MORRISVILLE, N.C., Jan. 26, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, will release its fourth quarter and full year 2020 financial results on Thursday, February 18, 2021, prior to its earnings call at 8:00 a.m. ET.
Participants may access the conference call live via webcast on the Investor Relations section of the Syneos Health website at investor.syneoshealth.com. To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call.
A webcast replay will be available on the Investor Relations section of the Syneos Health website at investor.syneoshealth.com after 1:00 p.m. on February 18.
About Syneos Health
Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. We bring together approximately 25,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are Shortening the distance from lab to life®, visit syneoshealth.com or subscribe to our podcast.
| Investor Relations Contact: | Press/Media Contact: | |
| Ronnie Speight | Gary Gatyas | |
| Senior Vice President, Investor Relations | Executive Director, External Communications | |
| +1 919 745 2745 | +1 908 763 3428 | |
| Investor.Relations@syneoshealth.com | gary.gatyas@syneoshealth.com |
FAQ
When will Syneos Health release its fourth quarter and full year 2020 financial results?
What time is the earnings call for Syneos Health's financial results?
How can I access the Syneos Health earnings call?
Is there a replay available for Syneos Health's earnings call?
